Table 2.
List of peptides used in T-cell in vitro tests.
Abbreviated name | Amino acid sequence in the regions of DR mutations | DR mutations (if applicable) | T-cell epitope (if applicable) |
---|---|---|---|
![]() | |||
RT_wt_opt-in | TPVFAIKKKDSTKWRKLVDFRELNKRTQ | ||
RT_1.14_opt-in | TPVFVIKKKNNTGWRKLIDLRELNKRTQ | ||
PEPTIDES | |||
RT 61–69 wt | ---FAIKKKDST---------------- | A62V, D67N, S68N | N/A |
RT 61–69 dr | ---FAIKKKNST---------------- | A62V, D67N, S68N | N/A |
RT 63–72 wt* | -----IKKKDSTKWR------------- | D67N, S68N, K70G | N/A |
RT 63–72 dr* | -----IKKKNNTGWR------------- | D67N, S68N, K70G | N/A |
RT 66–76 wt* | --------KDSTKWRKLVD--------- | D67N, S68N, K70G, V75I | N/A |
RT 66–76 dr* | --------KNNTGWRKLVD--------- | D67N, S68N, K70G, V75I | N/A |
RT 74–82 | ----------------LVDFRELNK--- | V75I, F77L | N/A |
![]() | |||
RT_wt_opt-in | RTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYEL | ||
RT_1.14_opt-in | RTKVEELREHLLRWGFYTPDQKHQKEPPFLWMGYEL | ||
PEPTIDES | |||
RT 199–216 wt | RTKIEELRTHLLRWGLTT------------------ | I202V, Q207E, L214F, T215Y | N/A |
RT 199–216 dr | RTKVEELREHLLRWGFY------------------- | I202V, Q207E, L214F, T215Y | N/A |
RT 202–210 wt | ---IEELRQHLL------------------------ | I202V, Q207E | N/A |
RT 202–210 dr | ---VEELREHLL------------------------ | 202V, Q207E | N/A |
RT 205–220 wt | ------LRQHLLRWGLTTPDQK-------------- | Q207E, L214F, T215Y, K219Q | N/A |
RT 205–220 dr | ------LREHLLRWGFYTPDQK-------------- | Q207E, L214F, T215Y, K219Q | N/A |
RT 207–215 wt | --------QHLLRWGLT------------------- | Q207E, L214F, T215Y | N/A |
RT 207–215 dr | --------EHLLRWGFY------------------- | Q207E, L214F, T215Y | N/A |
Peptides covering regions not subjected to DR mutations | |||
RT 465–476 | KVVPLTNTTNQK | N/A | CD8+ T-cells(a) |
RT 514–528 | ESELVNQIIEQLIKK | N/A | CD8+ T-cells(b) |
RT 528–543 | KEKVYLAWVPAHKGIG | N/A | CD4+ T-cells(c) |